4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-034349
Chief Financial Officer sold 2,500 shares at $17.17 ($42,925)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RAY DEBANJAN Chief Financial Officer | 2017-09-01 | Sale | −2,500 | $17.17 | $42,925 | 17,126 | D: show line 1 in the form |
| Open-market sales · 2,500 sh · avg $17.17 · $42,925 | |||||||
Loading xslF345X03/doc1.xml…